Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
暂无分享,去创建一个
M Marchetti | E Oldani | T. Barbui | C. Cerletti | A. Falanga | S. Giovanelli | V. Evangelista | S. Manarini | M. Galbusera | A Falanga | T Barbui | M Galbusera | S Manarini | V Evangelista | S Giovanelli | C Cerletti | M. Marchetti | E. Oldani
[1] B. Binder,et al. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. , 1994, The Journal of laboratory and clinical medicine.
[2] F. Holsboer,et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. , 1996, Blood.
[3] H. Scher,et al. Acute arterial thrombosis after escalated‐dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony‐stimulating factor: A possible new recombinant granulocyte colony‐stimulating factor toxicity , 1992, Cancer.
[4] Ulla-Britt Jönsson,et al. Effects of in vivo administration of G‐CSF on neutrophil and eosinophil adhesion , 1997, British journal of haematology.
[5] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[6] L. Iacoviello,et al. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes? , 1993, The Journal of laboratory and clinical medicine.
[7] R. Seitz,et al. Protein C degradation in vitro by neutrophil elastase. , 1991, Biological chemistry Hoppe-Seyler.
[8] J. Gabrilove. The development of granulocyte colony-stimulating factor in its various clinical applications. , 1992, Blood.
[9] C. Hack,et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. , 1994, Blood.
[10] T. Barbui,et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. , 1995, Blood.
[11] K. Miyazono,et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. , 1989, Blood.
[12] D. Linch,et al. Differential effects of granulocyte‐ and granulocyte‐macrophage colony‐stimulating factors (G‐ and GM‐CSF) on neutrophil adhesion in vitro and in vivo , 1992, European journal of haematology.
[13] C. Nathan. Respiratory burst in adherent human neutrophils: triggering by colony- stimulating factors CSF-GM and CSF-G , 1989 .
[14] E. Jaffe,et al. Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. , 1989, Blood.
[15] A. Blann,et al. A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST? , 1995, British journal of haematology.
[16] J. Kilpatrick,et al. Heparin promotes the inactivation of antithrombin by neutrophil elastase. , 1987, Science.
[17] P. Renesto,et al. Leucocyte elastase-mediated release of von Willebrand factor from cultured endothelial cells. , 1993, European Respiratory Journal.
[18] C. Cerletti,et al. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. , 1996, Blood.
[19] D. Dale,et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. , 1999, The Journal of infectious diseases.
[20] Z. Ruggeri,et al. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. , 1991, The Journal of clinical investigation.
[21] C. Cerletti,et al. Platelet Activation by Polymorphonuclear Leukocytes: Role of Cathepsin G and P-Selectin , 1995, Thrombosis and Haemostasis.
[22] J. Goldman. Peripheral blood stem cells for allografting. , 1995, Blood.
[23] A. Ohsaka,et al. Granulocyte colony‐stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes , 1995, British journal of haematology.
[24] T. Hartung,et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. , 1995, Blood.
[25] G. Remuzzi,et al. Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] T. Uchida,et al. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony‐stimulating factor , 1996, British journal of haematology.
[27] T. Barbui,et al. The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial , 1998, Thrombosis and Haemostasis.
[28] G. Broze,et al. The effect of leukocyte elastase on tissue factor pathway inhibitor. , 1992, Blood.
[29] M. Höglund,et al. The effect of granulocyte colony‐stimulating factor (G‐CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect , 1996, British journal of haematology.
[30] I. Ginsburg,et al. Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. , 1989, The American journal of pathology.
[31] R. Allen,et al. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. , 1994, Blood.
[33] A. Mantovani,et al. Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.
[34] L. Salvatore,et al. Neutrophil Derived Cathepsin G Induces Potentially Thrombogenic Changes in Human Endothelial Cells: a Scanning Electron Microscopy Study in Static and Dynamic Conditions , 1994, Thrombosis and Haemostasis.
[35] M. Chignard,et al. Cathepsin G is a strong platelet agonist released by neutrophils. , 1988, The Biochemical journal.
[36] P. Renesto,et al. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. , 1993, Blood.
[37] T. Okamura,et al. Granulocyte colony-stimulating factor and platelet aggregation , 1993, The Lancet.
[38] T. van der Poll,et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. , 1997, Blood.
[39] J. Goldman. Peripheral blood stem cells for allografting [editorial] [see comments] , 1995 .
[40] J. White,et al. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion. , 1993, Blood.
[41] E. Conway,et al. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. , 1992, Blood.
[42] T. Barbui,et al. Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis , 1996, Thrombosis and Haemostasis.
[43] William,et al. Structure and function of thrombomodulin: a natural anticoagulant. , 1990, Blood.
[44] Z. Ruggeri,et al. The complex multimeric composition of factor VIII/von Willebrand factor. , 1981, Blood.
[45] G. Striker,et al. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. , 1981, The Journal of clinical investigation.
[46] R. Seitz,et al. Protein S degradation in vitro by neutrophil elastase. , 1993, Scandinavian journal of clinical and laboratory investigation.
[47] M. Levine,et al. Hemostatic alterations in cancer patients. , 1992 .
[48] J. Griffin,et al. Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. , 1987, Journal of immunology.
[49] R. Champlin,et al. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. , 1996, Blood.
[50] S. Kondo,et al. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. , 1993, The Journal of clinical investigation.
[51] T. Carlos,et al. Leukocyte-endothelial adhesion molecules. , 1994, Blood.
[52] J. Platt,et al. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[53] B. Boneu,et al. Inactivation of heparin cofactor II by polymorphonuclear leukocytes. , 1987, Thrombosis research.
[54] G. Nash,et al. Selectin-mediated rolling of neutrophils on immobilized platelets. , 1993, Blood.
[55] M. Conese,et al. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies , 1990, International journal of cancer.
[56] J. Rivera,et al. Effect of G-CSF on the Haemostatic System , 1994, Thrombosis and Haemostasis.